×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

US FDA removes boxed warning on LABA+ ICS combination for asthma and COPD

  1002 Views

eMediNexus    22 December 2017

In an updated drug safety communication released on December 20, 2017, the US FDA has removed the Boxed Warning about asthma-related death from the drug labels of medicines that contain long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS).

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.